Risk factors assessment for radiographically guided port implantations with forearm access.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 14 07 2021
accepted: 06 10 2021
entrez: 26 10 2021
pubmed: 27 10 2021
medline: 15 12 2021
Statut: epublish

Résumé

Port implantations at the forearm are associated with an increased risk of relevant vein thrombosis. Therefore, with this study we sought to identify the responsible risk factors to improve technical quality of the method. This is a retrospective analysis of 313 patients with port implantation at the forearm in 2019. Then, exploratory statistics were conducted comprising Cox-Regression and Kaplan-Meier-Analyses. Mean age was 60 ± 14 years. 232 (74%) of the patients were female. No early infection was observed. 29 late infections and 57 cases of thrombosis occurred. In only 9% of the patients with thrombosis hospital admission was necessary for treatment. Median interval to the diagnosis of thrombosis was 23 days; inter-quartile-range: 16-75. Mean interval to elective port explantation was 227 ± 128 days. There was no effect of occurrence of thrombosis of the interventionalist, the assistance nor of several technical aspects. However, there was a significantly lower risk of thrombosis for primary implanted port system compared to replacement ports, Hazard-ratio: 0.34 [Confidence interval: 0.172, 0.674], p = 0.002. Age was a significant risk factor for late infections, Hazard-ratio: 3.35 [Confidence interval:1.84, 6.07], p < 0.0001. The main risk factor for adverse outcome after radiographically guided port implantation at the forearm is the type of the implanted port system. The reason for that might not be the material itself but the experience of a team with a certain port system. Age is a risk factor for late complications.

Identifiants

pubmed: 34699565
doi: 10.1371/journal.pone.0259127
pii: PONE-D-21-22930
pmc: PMC8547706
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0259127

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Semin Oncol. 2004 Apr;31(2):128-36
pubmed: 15112144
Insights Imaging. 2019 Aug 28;10(1):86
pubmed: 31463643
J Vasc Interv Radiol. 2000 Nov-Dec;11(10):1309-14
pubmed: 11099241
Ann Oncol. 2008 Jan;19(1):9-15
pubmed: 17846025
Eur Radiol. 2015 Mar;25(3):606-16
pubmed: 25239184
Cancer. 2007 Nov 15;110(10):2331-8
pubmed: 17886248
Cancer J. 2005 Nov-Dec;11(6):437-41
pubmed: 16393477
Pharmacol Ther. 2019 Sep;201:103-119
pubmed: 31028837
Exp Ther Med. 2011 Jul;2(4):675-684
pubmed: 22977559
Int J Nurs Stud. 2015 Mar;52(3):677-85
pubmed: 25593110
Cardiovasc Intervent Radiol. 2010 Dec;33(6):1159-67
pubmed: 20414657
J Vasc Interv Radiol. 2002 Feb;13(2 Pt 1):179-84
pubmed: 11830624
J Vasc Access. 2012 Jan-Mar;13(1):79-85
pubmed: 21786241

Auteurs

Jonathan Nadjiri (J)

Department of Interventional Radiology, University hospital Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Tobias Geith (T)

Department of Interventional Radiology, University hospital Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Tobias Waggershauser (T)

Department of Interventional Radiology, University hospital Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Stephan Forster (S)

Department of Interventional Radiology, University hospital Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Philipp Paprottka (P)

Department of Interventional Radiology, University hospital Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH